LT3140008T - Greitai veikiančios insulino kompozicijos - Google Patents

Greitai veikiančios insulino kompozicijos

Info

Publication number: LT3140008T
Authority: LT; Lithuania
Prior art keywords: rapid; acting insulin; insulin compositions; compositions; acting
Prior art date: 2014-05-08

Application number

LTEP15723388.3T

Other languages

English (en)

Inventor

Michael Edward CHRISTE

Thomas Andrew HARDY

Original Assignee

Eli Lilly And Company

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2014-05-08

Filing date

2015-05-04

Publication date

2019-05-27

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=53189204&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LT3140008(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2015-05-04 Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company

2019-05-27 Publication of LT3140008T publication Critical patent/LT3140008T/lt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/558—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes
- A61K31/5585—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes having five-membered rings containing oxygen as the only ring hetero atom, e.g. prostacyclin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Diabetes (AREA)
Bioinformatics & Cheminformatics (AREA)
Endocrinology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Hematology (AREA)
Obesity (AREA)
Oil, Petroleum & Natural Gas (AREA)
Inorganic Chemistry (AREA)
Emergency Medicine (AREA)
Dermatology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

LTEP15723388.3T 2014-05-08 2015-05-04 Greitai veikiančios insulino kompozicijos LT3140008T (lt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US201461990402P	2014-05-08	2014-05-08
PCT/US2015/029010 WO2015171484A1 (en)	2014-05-08	2015-05-04	Rapid-acting insulin compositions

Publications (1)

Publication Number	Publication Date
LT3140008T true LT3140008T (lt)	2019-05-27

Family

ID=53189204

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
LTEP15723388.3T LT3140008T (lt)	2014-05-08	2015-05-04	Greitai veikiančios insulino kompozicijos
LTEP19161129.2T LT3536380T (lt)	2014-05-08	2015-05-04	Greitai veikiančios insulino kompozicijos

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
LTEP19161129.2T LT3536380T (lt)	2014-05-08	2015-05-04	Greitai veikiančios insulino kompozicijos

Country Status (36)

Country	Link
US (2)	US9439952B2 (lt)
EP (3)	EP3140008B1 (lt)
JP (1)	JP6050902B2 (lt)
KR (1)	KR101858890B1 (lt)
CN (1)	CN106456717B (lt)
AP (1)	AP2016009525A0 (lt)
AR (1)	AR100155A1 (lt)
AU (1)	AU2015256355B2 (lt)
BR (1)	BR112016024357B1 (lt)
CA (1)	CA2945188C (lt)
CL (1)	CL2016002772A1 (lt)
CY (2)	CY1121669T1 (lt)
DK (2)	DK3536380T3 (lt)
EA (1)	EA031134B1 (lt)
ES (2)	ES2733639T3 (lt)
HR (2)	HRP20190777T1 (lt)
HU (2)	HUE044370T2 (lt)
IL (1)	IL248350B (lt)
JO (1)	JO3624B1 (lt)
LT (2)	LT3140008T (lt)
MA (1)	MA39441A1 (lt)
ME (1)	ME03384B (lt)
MX (1)	MX367521B (lt)
NZ (1)	NZ724919A (lt)
PE (1)	PE20161408A1 (lt)
PH (1)	PH12016502195B1 (lt)
PL (2)	PL3140008T3 (lt)
PT (2)	PT3536380T (lt)
RS (2)	RS58726B1 (lt)
SG (1)	SG11201608424WA (lt)
SI (2)	SI3536380T1 (lt)
TN (1)	TN2016000443A1 (lt)
TR (1)	TR201906843T4 (lt)
TW (1)	TWI685348B (lt)
UA (1)	UA124919C2 (lt)
WO (1)	WO2015171484A1 (lt)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK2910570T3 (en)	2008-03-18	2017-01-30	Novo Nordisk As	Protease-stabilized acylated insulin analogues.
EP2919804B1 (fr)	2012-11-13	2018-01-31	Adocia	Formulation à action rapide d'insuline comprenant un composé anionique substitué
JP6542128B2 (ja)	2013-01-11	2019-07-10	コルセアファーマインコーポレイテッド	トレプロスチニルのプロドラッグ
US9505737B2 (en)	2013-01-11	2016-11-29	Corsair Pharma, Inc.	Treprostinil derivative compounds and methods of using same
WO2017015760A1 (en) *	2015-07-28	2017-02-02	Societe De Commercialisation Des Produits De La Recherche Appliquee Socpra Sciences Sante Et Humaines, S.E.C.	A pharmaceutical preparation for improving absorption and postprandial hypoglycemic action of insulin
JO3749B1 (ar) *	2015-08-27	2021-01-31	Lilly Co Eli	تركيبات إنسولين سريعة المفعول
IL260823B2 (en) *	2016-01-29	2024-08-01	Mannkind Corp	Dry powder inhaler
GB201607918D0 (en)	2016-05-06	2016-06-22	Arecor Ltd	Novel formulations
EP3515430A1 (en)	2016-09-26	2019-07-31	United Therapeutics Corporation	Treprostinil prodrugs
WO2018060735A1 (en)	2016-09-29	2018-04-05	Arecor Limited	Novel formulations
TWI700091B (zh)	2016-12-16	2020-08-01	丹麥商諾佛儂迪克股份有限公司	含胰島素醫藥組成物
GB201707188D0 (en)	2017-05-05	2017-06-21	Arecor Ltd	Novel formulations
GB201707189D0 (en)	2017-05-05	2017-06-21	Arecor Ltd	Novel formulations
GB201707187D0 (en)	2017-05-05	2017-06-21	Arecor Ltd	Novel formulations
IL270975B2 (en)	2017-06-01	2024-02-01	Lilly Co Eli	Fast-acting insulin preparations
IL277721B2 (en)	2018-04-04	2024-03-01	Arecor Ltd	Medical infusion pump system for the delivery of an insulin compound
CA3094304A1 (en)	2018-04-04	2019-10-10	Arecor Limited	Medical infusion pump system for the delivery of an insulin compound
CN112040928A (zh)	2018-04-04	2020-12-04	艾瑞克有限公司	用于递送胰岛素化合物的医用输注泵系统
WO2019243627A1 (fr)	2018-06-23	2019-12-26	Adocia	Dispositif pour injecter une solution d'insuline(s)
FR3083985A1 (fr)	2018-07-23	2020-01-24	Adocia	Dispositif pour injecter une solution d'insuline(s)
EA202190552A1 (ru)	2018-09-18	2021-06-18	Эли Лилли Энд Компани	Эрбуминовая соль трепростинила
US10799564B1 (en) *	2019-05-06	2020-10-13	Baxter International Inc.	Insulin premix formulation and product, methods of preparing same, and methods of using same
WO2021009027A1 (en)	2019-07-12	2021-01-21	Novo Nordisk A/S	High concentration insulin formulation
EP4017588A1 (en)	2019-08-23	2022-06-29	United Therapeutics Corporation	Treprostinil prodrugs
GB202004814D0 (en)	2020-04-01	2020-05-13	Arecor Ltd	Novel formulations
CN115916212A (zh)	2020-04-17	2023-04-04	联合治疗公司	曲前列尼尔用于治疗间质性肺病
AU2021289336B2 (en)	2020-06-09	2025-08-28	Mannkind Corporation	Fumaryl diketopiperidine prodrugs of treprostinil
CN115697379A (zh) *	2020-06-30	2023-02-03	江苏恒瑞医药股份有限公司	速效胰岛素组合物及其医药用途
CN117062605A (zh)	2020-12-14	2023-11-14	联合治疗公司	使用曲前列环素前药治疗疾病的方法
CN117479946A (zh)	2021-03-03	2024-01-30	联合治疗公司	含曲前列环素及其前药并还包含(e)-3,6-双[4-(n-羰基-2-丙烯基)酰胺丁基]-2,5-二酮哌嗪(fdkp)的干粉组合物
JP2025515512A (ja) *	2022-04-29	2025-05-15	兆科薬業（広州）有限公司	トレプロスチニルソフトミスト吸入剤

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2740953A1 (de)	1977-09-12	1979-03-22	Thera Ges Fuer Patente	Verwendung von prostaglandinen zur senkung des blutzuckerspiegels
JPH10251146A (ja) *	1997-03-11	1998-09-22	Toray Ind Inc	糖尿病性神経障害の治療方法
WO2003020201A2 (en) *	2001-08-28	2003-03-13	Eli Lilly And Company	Pre-mixes of glp-1 and basal insulin
ATE496064T1 (de)	2002-05-07	2011-02-15	Novo Nordisk As	Lösliche formulierungen, die monomeres insulin und acyliertes insulin enthalten
DE602005020269D1 (de) *	2004-04-12	2010-05-12	United Therapeutics Corp	Verwendung von treprostinil zur behandlung von neuropathischen diabetischen fussgeschwüren
WO2009026517A2 (en) *	2007-08-22	2009-02-26	Gilead Colorado, Inc.	Therapy for complications of diabetes
US9387033B2 (en)	2008-08-28	2016-07-12	Roche Diabetes Care, Inc.	Device and method for enhanced subcutaneous insulin absorption
WO2010036798A1 (en) *	2008-09-25	2010-04-01	Aradigm Corporation	Deep lung pulmonary delivery of treprostinil
MX2011012764A (es) *	2009-06-26	2012-01-20	Novo Nordisk As	Preparacion que comprende insulina, nicotinamida y un aminoacido.
KR101701943B1 (ko) *	2009-11-13	2017-02-02	도레이 카부시키가이샤	당뇨병의 치료 또는 예방약
CA2821613A1 (en)	2010-12-14	2012-06-21	Novo Nordisk A/S	Preparation comprising insulin, nicotinamide and an amino acid
CA2843883C (en) *	2011-08-12	2020-04-28	Ascendis Pharma A/S	Carrier-linked treprostinil prodrugs
US9381247B2 (en) *	2012-04-16	2016-07-05	Biodel Inc.	Magnesium compositions for modulating the pharmacokinetics and pharmacodynamics of insulin and insulin analogs, and injection site pain
US20150065423A1 (en)	2013-08-30	2015-03-05	Perosphere, Inc.	Rapid acting injectable formulations
US20150273022A1 (en)	2014-02-10	2015-10-01	Biodel Inc.	Stabilized ultra-rapid-acting insulin formulations

2015
- 2015-04-21 TW TW104112752A patent/TWI685348B/zh active
- 2015-04-21 JO JOP/2015/0079A patent/JO3624B1/ar active
- 2015-04-22 AR ARP150101208A patent/AR100155A1/es not_active Application Discontinuation
- 2015-05-04 JP JP2015563152A patent/JP6050902B2/ja active Active
- 2015-05-04 MA MA39441A patent/MA39441A1/fr unknown
- 2015-05-04 AP AP2016009525A patent/AP2016009525A0/en unknown
- 2015-05-04 HR HRP20190777TT patent/HRP20190777T1/hr unknown
- 2015-05-04 SG SG11201608424WA patent/SG11201608424WA/en unknown
- 2015-05-04 SI SI201531655T patent/SI3536380T1/sl unknown
- 2015-05-04 TN TN2016000443A patent/TN2016000443A1/en unknown
- 2015-05-04 PL PL15723388T patent/PL3140008T3/pl unknown
- 2015-05-04 MX MX2016014643A patent/MX367521B/es active IP Right Grant
- 2015-05-04 HU HUE15723388 patent/HUE044370T2/hu unknown
- 2015-05-04 TR TR2019/06843T patent/TR201906843T4/tr unknown
- 2015-05-04 DK DK19161129.2T patent/DK3536380T3/da active
- 2015-05-04 CN CN201580024110.4A patent/CN106456717B/zh active Active
- 2015-05-04 NZ NZ724919A patent/NZ724919A/en unknown
- 2015-05-04 RS RS20190582A patent/RS58726B1/sr unknown
- 2015-05-04 DK DK15723388.3T patent/DK3140008T3/da active
- 2015-05-04 ES ES15723388T patent/ES2733639T3/es active Active
- 2015-05-04 UA UAA201611280A patent/UA124919C2/uk unknown
- 2015-05-04 WO PCT/US2015/029010 patent/WO2015171484A1/en not_active Ceased
- 2015-05-04 EP EP15723388.3A patent/EP3140008B1/en active Active
- 2015-05-04 RS RS20211085A patent/RS62291B1/sr unknown
- 2015-05-04 KR KR1020167031043A patent/KR101858890B1/ko active Active
- 2015-05-04 EP EP21183262.1A patent/EP3943155A1/en not_active Withdrawn
- 2015-05-04 SI SI201530716T patent/SI3140008T1/sl unknown
- 2015-05-04 PT PT191611292T patent/PT3536380T/pt unknown
- 2015-05-04 AU AU2015256355A patent/AU2015256355B2/en active Active
- 2015-05-04 ME MEP-2019-126A patent/ME03384B/me unknown
- 2015-05-04 CA CA2945188A patent/CA2945188C/en active Active
- 2015-05-04 US US14/781,342 patent/US9439952B2/en active Active
- 2015-05-04 PL PL19161129T patent/PL3536380T3/pl unknown
- 2015-05-04 PE PE2016002179A patent/PE20161408A1/es unknown
- 2015-05-04 LT LTEP15723388.3T patent/LT3140008T/lt unknown
- 2015-05-04 PT PT15723388T patent/PT3140008T/pt unknown
- 2015-05-04 BR BR112016024357-9A patent/BR112016024357B1/pt active IP Right Grant
- 2015-05-04 EA EA201691911A patent/EA031134B1/ru active Protection Beyond IP Right Term
- 2015-05-04 ES ES19161129T patent/ES2891983T3/es active Active
- 2015-05-04 LT LTEP19161129.2T patent/LT3536380T/lt unknown
- 2015-05-04 HU HUE19161129A patent/HUE055742T2/hu unknown
- 2015-05-04 EP EP19161129.2A patent/EP3536380B8/en active Active
2016
- 2016-09-08 US US15/259,101 patent/US10172922B2/en active Active
- 2016-10-13 IL IL248350A patent/IL248350B/en active IP Right Grant
- 2016-11-02 CL CL2016002772A patent/CL2016002772A1/es unknown
- 2016-11-04 PH PH12016502195A patent/PH12016502195B1/en unknown
2019
- 2019-05-31 CY CY20191100581T patent/CY1121669T1/el unknown
2021
- 2021-08-20 CY CY20211100747T patent/CY1124454T1/el unknown
- 2021-09-07 HR HRP20211415TT patent/HRP20211415T1/hr unknown

Also Published As

Publication number	Publication date
EP3536380B8 (en)	2021-09-22
WO2015171484A1 (en)	2015-11-12
CN106456717B (zh)	2020-01-17
TN2016000443A1 (en)	2018-04-04
MX367521B (es)	2019-08-26
SG11201608424WA (en)	2016-11-29
HUE055742T2 (hu)	2021-12-28
EP3536380B1 (en)	2021-07-07
IL248350B (en)	2020-03-31
US9439952B2 (en)	2016-09-13
CL2016002772A1 (es)	2017-06-09
DK3140008T3 (da)	2019-06-24
HRP20211415T1 (hr)	2021-12-10
SI3536380T1 (sl)	2021-09-30
MX2016014643A (es)	2017-03-06
ES2733639T3 (es)	2019-12-02
PE20161408A1 (es)	2016-12-28
US20160367640A1 (en)	2016-12-22
PL3536380T3 (pl)	2021-12-27
MA39441A1 (fr)	2017-06-30
US20160129087A1 (en)	2016-05-12
TR201906843T4 (tr)	2019-05-21
IL248350A0 (en)	2016-11-30
AP2016009525A0 (en)	2016-10-31
PT3536380T (pt)	2021-09-02
DK3536380T3 (da)	2021-08-02
TW201625291A (zh)	2016-07-16
AU2015256355B2 (en)	2017-09-14
KR101858890B1 (ko)	2018-05-16
PH12016502195A1 (en)	2017-02-06
UA124919C2 (uk)	2021-12-15
US10172922B2 (en)	2019-01-08
AU2015256355A1 (en)	2016-10-27
JP6050902B2 (ja)	2016-12-21
PT3140008T (pt)	2019-06-25
CA2945188A1 (en)	2015-11-12
EP3943155A1 (en)	2022-01-26
CN106456717A (zh)	2017-02-22
EA201691911A1 (ru)	2017-02-28
TWI685348B (zh)	2020-02-21
CY1124454T1 (el)	2022-07-22
JO3624B1 (ar)	2020-08-27
EP3536380A1 (en)	2019-09-11
EP3140008B1 (en)	2019-04-17
CY1121669T1 (el)	2020-07-31
BR112016024357B1 (pt)	2022-08-23
KR20160133567A (ko)	2016-11-22
BR112016024357A2 (pt)	2017-10-10
HRP20190777T1 (hr)	2019-08-23
AR100155A1 (es)	2016-09-14
NZ724919A (en)	2018-01-26
ME03384B (me)	2020-01-20
PL3140008T3 (pl)	2019-09-30
EA031134B1 (ru)	2018-11-30
LT3536380T (lt)	2021-08-10
ES2891983T3 (es)	2022-02-01
HUE044370T2 (hu)	2019-10-28
RS58726B1 (sr)	2019-06-28
PH12016502195B1 (en)	2017-02-06
SI3140008T1 (sl)	2019-06-28
EP3140008A1 (en)	2017-03-15
JP2016523807A (ja)	2016-08-12
RS62291B1 (sr)	2021-09-30
CA2945188C (en)	2018-12-11

Publication	Publication Date	Title
IL248350B (en)	2020-03-31	Fast-acting insulin preparations
PT3233108T (pt)	2022-05-05	Composições de insulina de atuação rápida
ZA201800511B (en)	2019-07-31	Rapid-acting insulin compositions
GB201501859D0 (en)	2015-03-18	Composition
GB201410905D0 (en)	2014-08-06	Composition
IL251703A0 (en)	2017-06-29	A pharmaceutical preparation with improved stability
SG11201704735WA (en)	2017-07-28	Composition
ZA201704464B (en)	2020-10-28	Composition
GB201403017D0 (en)	2014-04-09	Composition
GB201414910D0 (en)	2014-10-08	Composition
GB201403561D0 (en)	2014-04-16	Composition
IL270975A (en)	2020-01-30	Fast-acting insulin preparations
SI3217964T1 (sl)	2020-02-28	Sestavek
GB201414555D0 (en)	2014-10-01	Composition
GB201410493D0 (en)	2014-07-30	Composition
GB201519442D0 (en)	2015-12-16	Composition
ZA201606127B (en)	2018-05-30	Composition
GB201420628D0 (en)	2015-01-07	Composition
GB201415483D0 (en)	2014-10-15	Composition
GB201404390D0 (en)	2014-04-23	Composition
GB201402648D0 (en)	2014-04-02	Composition
IL250781A0 (en)	2017-04-30	preparation
GB201503484D0 (en)	2015-04-15	Composition
GB201502355D0 (en)	2015-04-01	Composition
GB201421660D0 (en)	2015-01-21	Composition